Ferge Kristin A 4

What Happened

• Kristin A. Ferge, a director of Neuraxis, Inc. (NRXS), was issued 21,598 shares of common stock as an award/compensation on January 22, 2026. The shares were valued at $4.63 each, for a total value of $99,999. The transaction is reported on a Form 4 as acquisition via grant (transaction code A).

Key Details

• Transaction date and price: 2026-01-22 at $4.63 per share (total value $99,999).
• Transaction type/code: Award/Grant (A) — shares issued as compensation for director services.
• Shares owned after transaction: Not specified in this Form 4 filing.
• Footnote: The shares were issued to the reporting person as compensation for services as an independent director of the issuer (see footnote F1).
• Filing timeliness: Form 4 was filed on 2026-01-30, eight days after the transaction date; this is later than the typical 2-business-day filing requirement and is therefore a late filing.

Context

• These shares were awarded as director compensation, which is a routine non-market transaction and does not by itself indicate the director buying or selling stock for investment reasons. Awards are commonly used to compensate outside directors and may vest over time depending on company policy (vesting not specified here).